PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE ORAL SOLUTION solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

DEXTROMETHORPHAN HYDROBROMIDE (UNII: 9D2RTI9KYH) (DEXTROMETHORPHAN - UNII:7355X3ROTS), PROMETHAZINE HYDROCHLORIDE (UNII: R61ZEH7I1I) (PROMETHAZINE - UNII:FF28EJQ494)

Available from:

ATLANTIC BIOLOGICALS CORP.

Administration route:

ORAL

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

Promethazine hydrochloride and dextromethorphan hydrobromide oral solution is indicated for the temporary relief of coughs and upper respiratory symptoms associated with allergy or the common cold. Dextromethorphan should not be used in patients receiving a monoamine oxidase inhibitor (MAOI) (see PRECAUTIONS, Drug Interactions). Promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. Antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. According to the WHO Expert Committee on Drug Dependence, dextromethorphan could produce very slight psychic dependence but no physical dependence.

Product summary:

This preparation is a clear oral solution with yellow color and pineapple menthol odor, containing promethazine hydrochloride 6.25 mg/5 mL, dextromethorphan hydrobromide 15 mg/5 mL and alcohol 7 percent, and is available in NDC 17856-0155-01  PROMETHAZINE (with DM) 15-6.25/5 - 5 ML CUP 72 ct UD Keep tightly closed. Protect from light. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container with a child-resistant closure as defined in the USP. Distributed by: ATLANTIC BIOLOGICALS CORP. MIAMI, FL 33179

Authorization status:

Abbreviated New Drug Application

Summary of Product characteristics

                                PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN
HYDROBROMIDE ORAL SOLUTION- PROMETHAZINE HYDROCHLORIDE AND
DEXTROMETHORPHAN HYDROBROMIDE ORAL SOLUTION SOLUTION
ATLANTIC BIOLOGICALS CORP.
----------
PROMETHAZINE DM ORAL SOLUTION
RX ONLY
DESCRIPTION
Each 5 mL (one teaspoonful), for oral administration contains:
Dextromethorphan
hydrobromide 15 mg; promethazine hydrochloride 6.25 mg. Alcohol 7%.
Inactive Ingredients: Ascorbic acid, citric acid, D&C yellow #10, FD&C
yellow #6,
menthol, methylparaben, orange pineapple flavor, propylene glycol,
propylparaben,
purified water, saccharin sodium, sodium benzoate, sodium citrate and
sucrose.
Dextromethorphan hydrobromide is a salt of the methyl ether of the
dextrorotatory
isomer of levorphanol, a narcotic analgesic. It is chemically
designated as 3-methoxy-17-
methyl-9α, 13α, 14α-morphinan hydrobromide monohydrate.
Dextromethorphan
hydrobromide occurs as white crystals sparingly soluble in water and
freely soluble in
alcohol. It has a molecular weight of 370.32, a molecular formula of
C
H
NO•HBr•H O, and the following structural formula:
18
25
2
Promethazine is a racemic compound. Promethazine hydrochloride, a
phenothiazine
derivative, is chemically designated as
10_H_-Phenothiazine-10-ethanamine, _N_,_N_, α-
trimethyl-monohydrochloride.
Promethazine hydrochloride occurs as a white to faint yellow,
practically odorless,
crystalline powder which slowly oxidizes and turns blue on prolonged
exposure to air. It
is soluble in water and freely soluble in alcohol. It has a molecular
weight of 320.88, a
molecular formula of C
H
N S•HCI, and the following structural formula:
17
20
2
CLINICAL PHARMACOLOGY
DEXTROMETHORPHAN:
Dextromethorphan is an antitussive agent and, unlike the isomeric
levorphanol, it has no
analgesic or addictive properties.
The drug acts centrally and elevates the threshold for coughing. It is
about equal to
codeine in depressing the cough reflex. In therapeutic dosage
dextromethorphan does
not inhibit ciliary activity.
Dextromethorphan is rapidly absor
                                
                                Read the complete document